Scholars Central

Research articlePublished 11 Apr 2015

Tumor expression of Nectin-4 as a prognostic marker in breast cancer

Authors: Hisham Al-Torky, Galal Aboul-Nagah, Tarek El-Fayomi, Hytham Fayed, Hanan Tayel, Mahmoud Sakr

Archives of Clinical and Experimental Surgery

Volume 4 · Issue 4 · Pages 178–184

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Identification of new molecular tumor associated biomarkers is the most important current challenge in cancer research. Nectin-4 is one of the Nectin glycoproteins, which are cell adhesion molecules have been involved in tumor biology. Objectives: The objective was to evaluate Nectin-4 expression by immunohistochemistry (IHC) as a prognostic tumor marker in breast cancer (BC). Patients and Methods: This study was carried out on 100 female patients with BC. Their ages ranged between 29 and 67 years, with a mean of 41.3 years. Fifty other age-matched patients, subjected to reduction mammoplasty, served as controls. Data collected prospectively included patient demographics and tumor characteristics, including histopathological type and grade, IHC for Nectin-4 expression, estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2-Neu). Patients were regularly followed-up for 2 years, recording loco-regional recurrence, distant metastasis, and mortality. Results: Nectin-4 expression by IHC was detected in 62% of BC patients, but in none of the tumor-free controls (P = 0.0001). Nectin-4 expression showed a statistically significant positive correlation with higher tumor grade (P = 0.003) and axillary lymph node involvement (P = 0.0001), but not with increasing tumor size (P = 0.273). It had a significant inverse correlation with ER and PR, and a significant positive correlation with HER2-Neu (P = 0.0001). Furthermore, there was a significant correlation between Nectin-4 expression and the development of distant metastases (P = 0.014), local recurrence (P = 0.046), and mortality (P = 0.049). Conclusions: Nectin-4 is a highly recommended biomarker for predicting progression and prognosis of BC.

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Clinical and Experimental Surgery
  • SubjectSurgery
  • BylineArticles whose byline prints “Hisham Al-Torky”
  • BylineArticles whose byline prints “Galal Aboul-Nagah”
  • BylineArticles whose byline prints “Tarek El-Fayomi”
  • BylineArticles whose byline prints “Hytham Fayed”
  • BylineArticles whose byline prints “Hanan Tayel”
  • BylineArticles whose byline prints “Mahmoud Sakr”